申请人:Takeda Chemical Industries, Ltd.
公开号:US05177087A1
公开(公告)日:1993-01-05
There is provided a cyclic amine compound of the formula ##STR1## wherein B means a saturated or unsaturated 5- to 7-membered aza-heterocyclic group which may be substituted; A means a bond or an alkylene or alkenylene group which may be substituted by hydrocarbon residues, oxo, hydroxyimino, and/or hydroxy, means either a single bond or a double bond (provided that when A means a bond, means a single bond); R.sub.2 and R.sub.3 independently mean a hydrogen atom or a hydrocarbon residue which may be substituted (provided that both of R.sub.2 and R.sub.3 are not hydrogen atoms) or jointly form a cyclic amino group together with the adjacent nitrogen atom, n is 0, 1 or 2 and p is 1 or 2 or a physiologically acceptable salt thereof. The compounds are useful for therapy of cerebral edema, acute symptoms in cerebral apoplexy and protection of brain and nerve cell, or useful as anticholinesterase or as brain function-improving agent.
提供一种具有以下结构的环状胺化合物 ##STR1## 其中B表示饱和或不饱和的5-至7-成员的氮杂环基团,可以被取代;A表示键或者烷基或烯基基团,可以被碳氢基团、羰基、羟亚胺基和/或羟基取代,表示单键或双键(当A表示键时,则表示单键);R.sub.2和R.sub.3独立地表示氢原子或者可以被取代的碳氢基团(前提是R.sub.2和R.sub.3都不是氢原子),或者与相邻氮原子共同形成环状氨基团,n为0、1或2,p为1或2,或其生理学上可接受的盐。这些化合物可用于治疗脑水肿、脑卒中急性症状和保护脑和神经细胞,或者用作抗胆碱酯酶或脑功能改善剂。